Original language | English |
---|---|
Pages (from-to) | 192-196 |
Number of pages | 5 |
Journal | Clinical and Experimental Allergy |
Volume | 52 |
Issue number | 1 |
Early online date | 6 Nov 2021 |
DOIs | |
Publication status | Published - Jan 2022 |
Bibliographical note
Funding Information:H.N.G. Oude Elberink's institution has received consultancy fees from ALK‐Abelló. H.N.G. Oude Elberink has received fees for delivering lectures from Chiesi, ALK‐Abelló and Meda, has received consultancy fees from ALK‐Abello, has received research support from Novartis, MEDA Pharma, Mead Johnson, ALK‐Abello, Shire and Chiesi and has received payment for developing educational presentations from ALK‐Abello. H. Röckmann is a member of the national advisory board Novartis, has received research support from Novartis and Pharming. The other authors declare that they have no relevant conflicts of interest.